Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Certified by Founder
Lodge
Laplace Interventional
start up
United States
- Plymouth, MN
- 25/07/2023
- Series B
- $12,900,000
Laplace Interventional is developing a minimally invasive transcatheter treatment for patients suffering from Tricuspid Regurgitation.
- Industry Medical Equipment Manufacturing
- Website N/A
- LinkedIn https://www.linkedin.com/company/laplaceint/
KrisAtWork | $3,000,000 | (Feb 25, 2026)
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)